Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Privia Health Group, Inc.PRVA · Entity 1532 | Director · Chief Executive Officer | May 11, 2026 | May 13, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Privia Health Group, Inc.
Report date May 11, 2026 · Filed May 13, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, $0.01 par value per shareSEC Table I · non-derivative | Direct | 434,357 |
Ending reported balance
After 2026-05-12 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2026-05-11 · Sale · Disposed 105,439 · Balance 450,004 F1: Certain of the sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person and certain of the sales represent a nondiscretionary sale of shares required to be sold by the Reporting Person pursuant to "sell to cover" transaction to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units. F2: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $22.28 to $23.10 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. Row 2 · 2026-05-12 · Sale · Disposed 15,647 · Balance 434,357 F3: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person |
Filing footnotes · ownership attribution and instrument terms
F1: Certain of the sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person and certain of the sales represent a nondiscretionary sale of shares required to be sold by the Reporting Person pursuant to "sell to cover" transaction to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units.
F2: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $22.28 to $23.10 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
F3: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 21, 2022 Filed Sep 23, 2022 20:16 UTC | Privia Health Group, Inc. PRVA · Entity 1532 | Exercise / conversionCommon Stock, $0.01 par value per share | 122,783 | $2.00 | $245,566.00 |
DisclosureSEC source: 0001759655-22-000134 · wf-form4_166396415687408.xml · nonDerivative · entry 1 Mehrotra Parth · CIK 0001858398 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 220,174 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 20, 2022 Filed Sep 21, 2022 21:48 UTC | Privia Health Group, Inc. PRVA · Entity 1532 | Exercise / conversionStock Option (Right to Purchase) · Derivative | 24,211 | $0.00 Strike: $2.00 | $0.00 |
DisclosureSEC source: 0001759655-22-000129 · wf-form4_166379690208402.xml · derivative · entry 24 Mehrotra Parth · CIK 0001858398 · President and COO 10b5-1 filing: Not disclosed Ownership: Indirect · By the Parth Mehrotra 2021 Trust Disclosed balance after: 0 Underlying: Common Stock · 24,211 shares Expires 2035-09-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F12 · derivative.exercise_date: All of the stock options are fully vested and exercisable. Read SEC document |
| September 20, 2022 Filed Sep 21, 2022 21:48 UTC | Privia Health Group, Inc. PRVA · Entity 1532 | Exercise / conversionStock Option (Right to Purchase) · Derivative | 39,494 | $0.00 Strike: $2.00 | $0.00 |
DisclosureSEC source: 0001759655-22-000129 · wf-form4_166379690208402.xml · derivative · entry 23 Mehrotra Parth · CIK 0001858398 · President and COO 10b5-1 filing: Not disclosed Ownership: Indirect · By the Parth Mehrotra 2021 Trust Disclosed balance after: 272,006 Underlying: Common Stock · 39,494 shares Expires 2034-12-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F12 · derivative.exercise_date: All of the stock options are fully vested and exercisable. Read SEC document |
| September 20, 2022 Filed Sep 21, 2022 21:48 UTC | Privia Health Group, Inc. PRVA · Entity 1532 | Exercise / conversionStock Option (Right to Purchase) · Derivative | 35,855 | $0.00 Strike: $2.00 | $0.00 |
DisclosureSEC source: 0001759655-22-000129 · wf-form4_166379690208402.xml · derivative · entry 22 Mehrotra Parth · CIK 0001858398 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 272,577 Underlying: Common Stock · 35,855 shares Expires 2034-12-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F11 · derivative.exercise_date: Reflects stock options to purchase shares of common stock of the Issuer under the Plan. Prior to the transactions reported in this Form 4, 252,395 of the stock options are fully vested and exercisable. 113,066 of the stock options will on October 29, 2022 and 46,446 of the stock options will vest on December 4, 2022. Read SEC document |
| September 20, 2022 Filed Sep 21, 2022 21:48 UTC | Privia Health Group, Inc. PRVA · Entity 1532 | Exercise / conversionStock Option (Right to Purchase) · Derivative | 30,156 | $0.00 Strike: $2.00 | $0.00 |
DisclosureSEC source: 0001759655-22-000129 · wf-form4_166379690208402.xml · derivative · entry 21 Mehrotra Parth · CIK 0001858398 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,280,463 Underlying: Common Stock · 30,156 shares Expires 2033-08-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F10 · derivative.exercise_date: Reflects stock options to purchase shares of common stock of the Issuer under the Plan. Prior to the transactions reported in this Form 4, 1,072,133 of the stock options are fully vested and exercisable. 273,559 of the stock options will vest on October 29, 2022. Read SEC document |
| September 20, 2022 Filed Sep 21, 2022 21:48 UTC | Privia Health Group, Inc. PRVA · Entity 1532 | SaleCommon Stock, par value $0.01 per share | 63,705 | $37.31 | $2,376,833.55 |
DisclosureSEC source: 0001759655-22-000129 · wf-form4_166379690208402.xml · nonDerivative · entry 16 Mehrotra Parth · CIK 0001858398 · President and COO 10b5-1 filing: Not disclosed Ownership: Indirect · By the Parth Mehrotra 2021 Trust Disclosed balance after: 0 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 15, 2022. F9 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $36.90 to $37.79 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. Read SEC document |
| September 20, 2022 Filed Sep 21, 2022 21:48 UTC | Privia Health Group, Inc. PRVA · Entity 1532 | Exercise / conversionCommon Stock, par value $0.01 per share | 24,211 | $2.00 | $48,422.00 |
DisclosureSEC source: 0001759655-22-000129 · wf-form4_166379690208402.xml · nonDerivative · entry 15 Mehrotra Parth · CIK 0001858398 · President and COO 10b5-1 filing: Not disclosed Ownership: Indirect · By the Parth Mehrotra 2021 Trust Disclosed balance after: 63,705 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 20, 2022 Filed Sep 21, 2022 21:48 UTC | Privia Health Group, Inc. PRVA · Entity 1532 | Exercise / conversionCommon Stock, par value $0.01 per share | 39,494 | $2.00 | $78,988.00 |
DisclosureSEC source: 0001759655-22-000129 · wf-form4_166379690208402.xml · nonDerivative · entry 14 Mehrotra Parth · CIK 0001858398 · President and COO 10b5-1 filing: Not disclosed Ownership: Indirect · By the Parth Mehrotra 2021 Trust Disclosed balance after: 39,494 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 20, 2022 Filed Sep 21, 2022 21:48 UTC | Privia Health Group, Inc. PRVA · Entity 1532 | SaleCommon Stock, $0.01 par value per share | 66,011 | $37.30 | $2,462,210.30 |
DisclosureSEC source: 0001759655-22-000129 · wf-form4_166379690208402.xml · nonDerivative · entry 13 Mehrotra Parth · CIK 0001858398 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,391 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 15, 2022. F8 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $36.89 to $37.79 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. Read SEC document |
| September 20, 2022 Filed Sep 21, 2022 21:48 UTC | Privia Health Group, Inc. PRVA · Entity 1532 | Exercise / conversionCommon Stock, par value $0.01 per share | 35,855 | $2.00 | $71,710.00 |
DisclosureSEC source: 0001759655-22-000129 · wf-form4_166379690208402.xml · nonDerivative · entry 12 Mehrotra Parth · CIK 0001858398 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 163,402 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 20, 2022 Filed Sep 21, 2022 21:48 UTC | Privia Health Group, Inc. PRVA · Entity 1532 | Exercise / conversionCommon Stock, par value $0.01 per share | 30,156 | $2.00 | $60,312.00 |
DisclosureSEC source: 0001759655-22-000129 · wf-form4_166379690208402.xml · nonDerivative · entry 11 Mehrotra Parth · CIK 0001858398 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 127,547 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 19, 2022 Filed Sep 21, 2022 21:48 UTC | Privia Health Group, Inc. PRVA · Entity 1532 | Exercise / conversionStock Option (Right to Purchase) · Derivative | 80,005 | $0.00 Strike: $2.00 | $0.00 |
DisclosureSEC source: 0001759655-22-000129 · wf-form4_166379690208402.xml · derivative · entry 20 Mehrotra Parth · CIK 0001858398 · President and COO 10b5-1 filing: Not disclosed Ownership: Indirect · By the Parth Mehrotra 2021 Trust Disclosed balance after: 24,211 Underlying: Common Stock · 80,005 shares Expires 2035-09-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F12 · derivative.exercise_date: All of the stock options are fully vested and exercisable. Read SEC document |
| September 19, 2022 Filed Sep 21, 2022 21:48 UTC | Privia Health Group, Inc. PRVA · Entity 1532 | Exercise / conversionStock Option (Right to Purchase) · Derivative | 27,697 | $0.00 Strike: $2.00 | $0.00 |
DisclosureSEC source: 0001759655-22-000129 · wf-form4_166379690208402.xml · derivative · entry 19 Mehrotra Parth · CIK 0001858398 · President and COO 10b5-1 filing: Not disclosed Ownership: Indirect · By the Parth Mehrotra 2021 Trust Disclosed balance after: 311,500 Underlying: Common Stock · 27,697 shares Expires 2034-12-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F12 · derivative.exercise_date: All of the stock options are fully vested and exercisable. Read SEC document |
| September 19, 2022 Filed Sep 21, 2022 21:48 UTC | Privia Health Group, Inc. PRVA · Entity 1532 | Exercise / conversionStock Option (Right to Purchase) · Derivative | 103,474 | $0.00 Strike: $2.00 | $0.00 |
DisclosureSEC source: 0001759655-22-000129 · wf-form4_166379690208402.xml · derivative · entry 18 Mehrotra Parth · CIK 0001858398 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 308,432 Underlying: Common Stock · 103,474 shares Expires 2034-12-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F11 · derivative.exercise_date: Reflects stock options to purchase shares of common stock of the Issuer under the Plan. Prior to the transactions reported in this Form 4, 252,395 of the stock options are fully vested and exercisable. 113,066 of the stock options will on October 29, 2022 and 46,446 of the stock options will vest on December 4, 2022. Read SEC document |
| September 19, 2022 Filed Sep 21, 2022 21:48 UTC | Privia Health Group, Inc. PRVA · Entity 1532 | Exercise / conversionStock Option (Right to Purchase) · Derivative | 35,073 | $0.00 Strike: $2.00 | $0.00 |
DisclosureSEC source: 0001759655-22-000129 · wf-form4_166379690208402.xml · derivative · entry 17 Mehrotra Parth · CIK 0001858398 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,310,619 Underlying: Common Stock · 35,073 shares Expires 2033-08-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F10 · derivative.exercise_date: Reflects stock options to purchase shares of common stock of the Issuer under the Plan. Prior to the transactions reported in this Form 4, 1,072,133 of the stock options are fully vested and exercisable. 273,559 of the stock options will vest on October 29, 2022. Read SEC document |
| September 19, 2022 Filed Sep 21, 2022 21:48 UTC | Privia Health Group, Inc. PRVA · Entity 1532 | SaleCommon Stock, par value $0.01 per share | 2,540 | $38.89 | $98,780.60 |
DisclosureSEC source: 0001759655-22-000129 · wf-form4_166379690208402.xml · nonDerivative · entry 10 Mehrotra Parth · CIK 0001858398 · President and COO 10b5-1 filing: Not disclosed Ownership: Indirect · By the Parth Mehrotra 2021 Trust Disclosed balance after: 0 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 15, 2022. F7 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $38.79 to $39.05 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. Read SEC document |
| September 19, 2022 Filed Sep 21, 2022 21:48 UTC | Privia Health Group, Inc. PRVA · Entity 1532 | SaleCommon Stock, par value $0.01 per share | 67,720 | $37.96 | $2,570,651.20 |
DisclosureSEC source: 0001759655-22-000129 · wf-form4_166379690208402.xml · nonDerivative · entry 9 Mehrotra Parth · CIK 0001858398 · President and COO 10b5-1 filing: Not disclosed Ownership: Indirect · By the Parth Mehrotra 2021 Trust Disclosed balance after: 2,540 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 15, 2022. F6 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $37.78 to $38.77 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. Read SEC document |
| September 19, 2022 Filed Sep 21, 2022 21:48 UTC | Privia Health Group, Inc. PRVA · Entity 1532 | SaleCommon Stock, par value $0.01 per share | 37,442 | $37.48 | $1,403,326.16 |
DisclosureSEC source: 0001759655-22-000129 · wf-form4_166379690208402.xml · nonDerivative · entry 8 Mehrotra Parth · CIK 0001858398 · President and COO 10b5-1 filing: Not disclosed Ownership: Indirect · By the Parth Mehrotra 2021 Trust Disclosed balance after: 70,260 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 15, 2022. F5 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $36.78 to $37.77 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. Read SEC document |
| September 19, 2022 Filed Sep 21, 2022 21:48 UTC | Privia Health Group, Inc. PRVA · Entity 1532 | Exercise / conversionCommon Stock, par value $0.01 per share | 80,005 | $2.00 | $160,010.00 |
DisclosureSEC source: 0001759655-22-000129 · wf-form4_166379690208402.xml · nonDerivative · entry 7 Mehrotra Parth · CIK 0001858398 · President and COO 10b5-1 filing: Not disclosed Ownership: Indirect · By the Parth Mehrotra 2021 Trust Disclosed balance after: 107,702 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 19, 2022 Filed Sep 21, 2022 21:48 UTC | Privia Health Group, Inc. PRVA · Entity 1532 | Exercise / conversionCommon Stock, par value $0.01 per share | 27,697 | $2.00 | $55,394.00 |
DisclosureSEC source: 0001759655-22-000129 · wf-form4_166379690208402.xml · nonDerivative · entry 6 Mehrotra Parth · CIK 0001858398 · President and COO 10b5-1 filing: Not disclosed Ownership: Indirect · By the Parth Mehrotra 2021 Trust Disclosed balance after: 27,697 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 19, 2022 Filed Sep 21, 2022 21:48 UTC | Privia Health Group, Inc. PRVA · Entity 1532 | SaleCommon Stock, par value $0.01 per share | 2,230 | $38.94 | $86,836.20 |
DisclosureSEC source: 0001759655-22-000129 · wf-form4_166379690208402.xml · nonDerivative · entry 5 Mehrotra Parth · CIK 0001858398 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,391 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 15, 2022. F4 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $38.82 to $39.12 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. Read SEC document |
| September 19, 2022 Filed Sep 21, 2022 21:48 UTC | Privia Health Group, Inc. PRVA · Entity 1532 | SaleCommon Stock, par value $0.01 per share | 60,700 | $38.10 | $2,312,670.00 |
DisclosureSEC source: 0001759655-22-000129 · wf-form4_166379690208402.xml · nonDerivative · entry 4 Mehrotra Parth · CIK 0001858398 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 99,621 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 15, 2022. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $37.82 to $38.79 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. Read SEC document |
| September 19, 2022 Filed Sep 21, 2022 21:48 UTC | Privia Health Group, Inc. PRVA · Entity 1532 | SaleCommon Stock, par value $0.01 per share | 75,617 | $37.60 | $2,843,199.20 |
DisclosureSEC source: 0001759655-22-000129 · wf-form4_166379690208402.xml · nonDerivative · entry 3 Mehrotra Parth · CIK 0001858398 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 160,321 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 15, 2022. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $36.82 to $37.81 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. Read SEC document |
| September 19, 2022 Filed Sep 21, 2022 21:48 UTC | Privia Health Group, Inc. PRVA · Entity 1532 | Exercise / conversionCommon Stock, par value $0.01 per share | 103,474 | $2.00 | $206,948.00 |
DisclosureSEC source: 0001759655-22-000129 · wf-form4_166379690208402.xml · nonDerivative · entry 2 Mehrotra Parth · CIK 0001858398 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 235,938 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 19, 2022 Filed Sep 21, 2022 21:48 UTC | Privia Health Group, Inc. PRVA · Entity 1532 | Exercise / conversionCommon Stock, par value $0.01 per share | 35,073 | $2.00 | $70,146.00 |
DisclosureSEC source: 0001759655-22-000129 · wf-form4_166379690208402.xml · nonDerivative · entry 1 Mehrotra Parth · CIK 0001858398 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 132,464 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 02, 2022 Filed Aug 4, 2022 20:12 UTC | Privia Health Group, Inc. PRVA · Entity 1532 | Exercise / conversionStock Option (Right to Purchase) · Derivative | 100,000 | $0.00 Strike: $2.00 | $0.00 |
DisclosureSEC source: 0001759655-22-000111 · wf-form4_165964391107769.xml · derivative · entry 5 Mehrotra Parth · CIK 0001858398 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,345,692 Underlying: Common Stock · 100,000 shares Expires 2033-08-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: Reflects stock options to purchase shares of common stock of the Issuer under the Plan. Prior to the transactions reported in this Form 4, 1,172,133 of the stock options are fully vested and exercisable.273,559 of the stock options will vest on October 29, 2022. Read SEC document |
| August 02, 2022 Filed Aug 4, 2022 20:12 UTC | Privia Health Group, Inc. PRVA · Entity 1532 | SaleCommon Stock, par value $0.01 per share | 2,051 | $38.68 | $79,332.68 |
DisclosureSEC source: 0001759655-22-000111 · wf-form4_165964391107769.xml · nonDerivative · entry 4 Mehrotra Parth · CIK 0001858398 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,391 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 11, 2021. F4 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $38.65 to $38.71 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. Read SEC document |
| August 02, 2022 Filed Aug 4, 2022 20:12 UTC | Privia Health Group, Inc. PRVA · Entity 1532 | SaleCommon Stock, par value $0.01 per share | 92,774 | $38.25 | $3,548,605.50 |
DisclosureSEC source: 0001759655-22-000111 · wf-form4_165964391107769.xml · nonDerivative · entry 3 Mehrotra Parth · CIK 0001858398 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 99,442 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 11, 2021. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $37.65 to $38.64 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. Read SEC document |
| August 02, 2022 Filed Aug 4, 2022 20:12 UTC | Privia Health Group, Inc. PRVA · Entity 1532 | SaleCommon Stock, par value $0.01 per share | 5,175 | $37.42 | $193,648.50 |
DisclosureSEC source: 0001759655-22-000111 · wf-form4_165964391107769.xml · nonDerivative · entry 2 Mehrotra Parth · CIK 0001858398 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 192,216 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 11, 2021. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $36.65 to $37.64 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. Read SEC document |
| August 02, 2022 Filed Aug 4, 2022 20:12 UTC | Privia Health Group, Inc. PRVA · Entity 1532 | Exercise / conversionCommon Stock, par value $0.01 per share | 100,000 | $2.00 | $200,000.00 |
DisclosureSEC source: 0001759655-22-000111 · wf-form4_165964391107769.xml · nonDerivative · entry 1 Mehrotra Parth · CIK 0001858398 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 197,391 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 20, 2022 Filed Jul 21, 2022 20:43 UTC | Privia Health Group, Inc. PRVA · Entity 1532 | Exercise / conversionStock Option (Right to Purchase) · Derivative | 60,000 | $0.00 Strike: $2.00 | $0.00 |
DisclosureSEC source: 0001759655-22-000105 · wf-form4_165843619443320.xml · derivative · entry 4 Mehrotra Parth · CIK 0001858398 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,445,692 Underlying: Common Stock · 60,000 shares Expires 2033-08-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Reflects stock options to purchase shares of common stock of the Issuer under the Plan. Prior to the transactions reported in this Form 4, 1,232,133 of the stock options are fully vested and exercisable. 273,559 of the stock options will vest on October 29, 2022. Read SEC document |
| July 20, 2022 Filed Jul 21, 2022 20:43 UTC | Privia Health Group, Inc. PRVA · Entity 1532 | SaleCommon Stock, par value $0.01 per share | 4,419 | $34.49 | $152,411.31 |
DisclosureSEC source: 0001759655-22-000105 · wf-form4_165843619443320.xml · nonDerivative · entry 3 Mehrotra Parth · CIK 0001858398 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,391 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 11, 2021. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $34.41 to $34.61 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. Read SEC document |
| July 20, 2022 Filed Jul 21, 2022 20:43 UTC | Privia Health Group, Inc. PRVA · Entity 1532 | SaleCommon Stock, par value $0.01 per share | 55,581 | $34.03 | $1,891,421.43 |
DisclosureSEC source: 0001759655-22-000105 · wf-form4_165843619443320.xml · nonDerivative · entry 2 Mehrotra Parth · CIK 0001858398 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 101,810 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 11, 2021. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $33.41 to $34.40 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. Read SEC document |
| July 20, 2022 Filed Jul 21, 2022 20:43 UTC | Privia Health Group, Inc. PRVA · Entity 1532 | Exercise / conversionCommon Stock, par value $0.01 per share | 60,000 | $2.00 | $120,000.00 |
DisclosureSEC source: 0001759655-22-000105 · wf-form4_165843619443320.xml · nonDerivative · entry 1 Mehrotra Parth · CIK 0001858398 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 157,391 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 15, 2022 Filed Jul 19, 2022 20:53 UTC | Privia Health Group, Inc. PRVA · Entity 1532 | Exercise / conversionStock Option (Right to Purchase) · Derivative | 27,265 | $0.00 Strike: $2.00 | $0.00 |
DisclosureSEC source: 0001759655-22-000100 · wf-form4_165826401947482.xml · derivative · entry 4 Mehrotra Parth · CIK 0001858398 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,505,692 Underlying: Common Stock · 27,265 shares Expires 2033-08-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Reflects stock options to purchase shares of common stock of the Issuer under the Plan. Prior to the transactions reported in this Form 4, 1,259,398 of the stock options are fully vested and exercisable. 273,559 of the stock options will vest on October 29, 2022. Read SEC document |
| July 15, 2022 Filed Jul 19, 2022 20:53 UTC | Privia Health Group, Inc. PRVA · Entity 1532 | SaleCommon Stock, par value $0.01 per share | 3,827 | $35.01 | $133,971.79 |
DisclosureSEC source: 0001759655-22-000100 · wf-form4_165826401947482.xml · nonDerivative · entry 3 Mehrotra Parth · CIK 0001858398 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,391 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 11, 2021. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $35.00 to $35.04 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. Read SEC document |
| July 15, 2022 Filed Jul 19, 2022 20:53 UTC | Privia Health Group, Inc. PRVA · Entity 1532 | SaleCommon Stock, par value $0.01 per share | 23,438 | $34.74 | $814,306.43 |
DisclosureSEC source: 0001759655-22-000100 · wf-form4_165826401947482.xml · nonDerivative · entry 2 Mehrotra Parth · CIK 0001858398 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 101,218 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 11, 2021. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $34.00 to $34.99 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. Read SEC document |
| July 15, 2022 Filed Jul 19, 2022 20:53 UTC | Privia Health Group, Inc. PRVA · Entity 1532 | Exercise / conversionCommon Stock, par value $0.01 per share | 27,265 | $2.00 | $54,530.00 |
DisclosureSEC source: 0001759655-22-000100 · wf-form4_165826401947482.xml · nonDerivative · entry 1 Mehrotra Parth · CIK 0001858398 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 124,656 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 08, 2022 Filed Jul 11, 2022 20:26 UTC | Privia Health Group, Inc. PRVA · Entity 1532 | Exercise / conversionStock Option (Right to Purchase) · Derivative | 12,735 | $0.00 Strike: $2.00 | $0.00 |
DisclosureSEC source: 0001759655-22-000095 · wf-form4_165757117090739.xml · derivative · entry 3 Mehrotra Parth · CIK 0001858398 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,532,957 Underlying: Common Stock · 12,735 shares Expires 2033-08-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Reflects stock options to purchase shares of common stock of the Issuer under the Plan. Prior to the transactions reported in this Form 4, 1,272,133 of the stock options are fully vested and exercisable. 273,559 of the stock options will vest on October 29, 2022. Read SEC document |
| July 08, 2022 Filed Jul 11, 2022 20:26 UTC | Privia Health Group, Inc. PRVA · Entity 1532 | SaleCommon Stock | 12,735 | $34.23 | $435,880.85 |
DisclosureSEC source: 0001759655-22-000095 · wf-form4_165757117090739.xml · nonDerivative · entry 2 Mehrotra Parth · CIK 0001858398 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,391 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 11, 2021. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $34.00 to $34.74 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. Read SEC document |
| July 08, 2022 Filed Jul 11, 2022 20:26 UTC | Privia Health Group, Inc. PRVA · Entity 1532 | Exercise / conversionCommon Stock | 12,735 | $2.00 | $25,470.00 |
DisclosureSEC source: 0001759655-22-000095 · wf-form4_165757117090739.xml · nonDerivative · entry 1 Mehrotra Parth · CIK 0001858398 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,126 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 05, 2022 Filed Jul 7, 2022 22:26 UTC | Privia Health Group, Inc. PRVA · Entity 1532 | Exercise / conversionStock Option (Right to Purchase) · Derivative | 40,000 | $0.00 Strike: $2.00 | $0.00 |
DisclosureSEC source: 0001759655-22-000088 · wf-form4_165723279734220.xml · derivative · entry 7 Mehrotra Parth · CIK 0001858398 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,545,692 Underlying: Common Stock · 40,000 shares Expires 2033-08-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: Reflects stock options to purchase shares of common stock of the Issuer under the Plan. 1,312,132 of the stock options are fully vested and exercisable. 273,560 of the stock options will vest on October 29, 2022. Read SEC document |
| July 05, 2022 Filed Jul 7, 2022 22:26 UTC | Privia Health Group, Inc. PRVA · Entity 1532 | SaleCommon Stock, $0.01 par value per share | 300 | $32.50 | $9,750.00 |
DisclosureSEC source: 0001759655-22-000088 · wf-form4_165723279734220.xml · nonDerivative · entry 6 Mehrotra Parth · CIK 0001858398 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,391 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 11, 2021. F6 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $32.43 to $32.54 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. Read SEC document |
| July 05, 2022 Filed Jul 7, 2022 22:26 UTC | Privia Health Group, Inc. PRVA · Entity 1532 | SaleCommon Stock, $0.01 par value per share | 1,137 | $31.36 | $35,656.32 |
DisclosureSEC source: 0001759655-22-000088 · wf-form4_165723279734220.xml · nonDerivative · entry 5 Mehrotra Parth · CIK 0001858398 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,691 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 11, 2021. F5 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $31.07 to $31.95 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. Read SEC document |
| July 05, 2022 Filed Jul 7, 2022 22:26 UTC | Privia Health Group, Inc. PRVA · Entity 1532 | SaleCommon Stock, $0.01 par value per share | 15,594 | $30.64 | $477,800.16 |
DisclosureSEC source: 0001759655-22-000088 · wf-form4_165723279734220.xml · nonDerivative · entry 4 Mehrotra Parth · CIK 0001858398 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 98,828 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 11, 2021. F4 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $30.02 to $30.98 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. Read SEC document |
| July 05, 2022 Filed Jul 7, 2022 22:26 UTC | Privia Health Group, Inc. PRVA · Entity 1532 | SaleCommon Stock, $0.01 par value per share | 20,979 | $29.41 | $616,992.39 |
DisclosureSEC source: 0001759655-22-000088 · wf-form4_165723279734220.xml · nonDerivative · entry 3 Mehrotra Parth · CIK 0001858398 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 114,422 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 11, 2021. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $29.02 to $29.99 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. Read SEC document |
| July 05, 2022 Filed Jul 7, 2022 22:26 UTC | Privia Health Group, Inc. PRVA · Entity 1532 | SaleCommon Stock, $0.01 par value per share | 1,990 | $28.70 | $57,113.00 |
DisclosureSEC source: 0001759655-22-000088 · wf-form4_165723279734220.xml · nonDerivative · entry 2 Mehrotra Parth · CIK 0001858398 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 135,401 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 11, 2021. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $28.00 to $28.99 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. Read SEC document |
| July 05, 2022 Filed Jul 7, 2022 22:26 UTC | Privia Health Group, Inc. PRVA · Entity 1532 | Exercise / conversionCommon Stock, $0.01 par value per share | 40,000 | $2.00 | $80,000.00 |
DisclosureSEC source: 0001759655-22-000088 · wf-form4_165723279734220.xml · nonDerivative · entry 1 Mehrotra Parth · CIK 0001858398 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 137,391 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 21, 2022 Filed Jun 23, 2022 20:08 UTC | Privia Health Group, Inc. PRVA · Entity 1532 | Exercise / conversionStock Option (Right to Purchase) · Derivative | 60,000 | $0.00 Strike: $2.00 | $0.00 |
DisclosureSEC source: 0001759655-22-000071 · wf-form4_165601487061281.xml · derivative · entry 4 Mehrotra Parth · CIK 0001858398 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,585,692 Underlying: Common Stock · 60,000 shares Expires 2033-08-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 21, 2022 Filed Jun 23, 2022 20:08 UTC | Privia Health Group, Inc. PRVA · Entity 1532 | SaleCommon Stock, $0.01 par value per share | 17,479 | $29.63 | $517,902.77 |
DisclosureSEC source: 0001759655-22-000071 · wf-form4_165601487061281.xml · nonDerivative · entry 3 Mehrotra Parth · CIK 0001858398 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,391 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 11, 2021. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $29.39 to $29.85 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.